New future of cell biology and toxicology: thinking deeper
Jianying Gu,Xiangdong Wang
DOI: https://doi.org/10.1007/s10565-016-9313-5
2016-01-01
Cell Biology and Toxicology
Abstract:The combination of cell biology and toxicology (CBTo) demonstrates the potential effects of elements in cellular structures, organelles, functioning properties, metabolic circles, signaling pathways, or interactions with the microenvironment. These elements not only include chemicals and drugs, but one should also consider food, water, and even the air we breathe. Thus, a number of toxicology subspecialties are developed and will be furthermore defined with the development of biotechnologies and our further understanding of toxicogenomics and ecotoxicology or aquatic, chemical, clinical, environmental, forensic, medical, occupational, and regulatory toxicology. Thus, future issues of the journal will focus on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. The merger of cell biology and toxicology enables a deeper insight of human disease-oriented and directed clinical research and science on geneand protein-based regulation, cell type-specific function, and system biomedicine in drug discovery and development (Abraham, et al. 2012; Wang and Marincola. 2012). It is well accepted that Bside effects^ or Btoxic effects^ of elements from extracellular, intercellular, or intracellular resources contribute to the pathogeneses and exacerbations of diseases. During this process, we explore geneand protein-based regulations using genomics and proteomics, functional genomics and proteomics, computational biology, and gene expression and function analysis. The combination of cell biology and toxicology is a critical and important approach to figure out multifactorial genetics and epigenetics of diseases to develop the strategy of precision medicine and disease-specific biomarkers to monitor the deterioration of the disease and efficiency of therapies, developmental biology, and system biology to understand multi-dimensional principles of element actions or bioinformatics-based data mining approaches to paint the full picture of the disease. However, there is a considerable lack in our understanding of how an existing disease per se can reduce or increase the cell sensitivity and response to elements. For example, astrocytes as central nervous system glial cells in the disease change their biological behaviors and functions, resulting in the disorder of extracellular ion and neurotransmitter exchanges and dysfunction of the blood-brain barrier (Tangye et al. 2015). Pathological astrocytes will alter the diffusion speed of elements and reduce resistance of nervous cells, promoting and maintaining the Bside effect.^ The effect of combining the study of cell biology and toxicology to aid the identification of molecular targets during discovery and development of target-based drugs Cell Biol Toxicol (2016) 32:1–3 DOI 10.1007/s10565-016-9313-5